NeuroOne announced preliminary fourth quarter 2026 revenue growth of 38.4% and full-year results at the high end of its guidance range. The company's performance was bolstered by the receipt of its largest-ever purchase order, significantly increasing visibility for the upcoming fiscal year.
Key Highlights
- Preliminary full-year 2026 revenue of $10.5 million reached the top of the previously issued $9.2 million to $10.5 million guidance range.
- Fourth quarter revenue grew 38.4% year-over-year to $3.8 million, up from $2.7 million in the same period last year.
- Secured a record $4.5 million purchase order in September, with $3.6 million of the balance scheduled to ship in the first and second quarters of fiscal 2027.
- Total open purchase orders reached $5.4 million as of September 30, 2026, providing a strong baseline for 2027 growth.